129 related articles for article (PubMed ID: 14981959)
1. Disruption of basement membrane, extracellular matrix metalloproteinases and E-cadherin in renal-cell carcinoma.
Morell-Quadreny L; Rubio J; Lopez-Guerrero JA; Casanova J; Ramos D; Iborra I; Solsona E; Llombart-Bosch A
Anticancer Res; 2003; 23(6D):5005-10. PubMed ID: 14981959
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.
Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Julián-González R; Galindo-Villardón P; Cruz-Hernández JJ; Bullón-Sopelana A
Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E100-5. PubMed ID: 16505783
[TBL] [Abstract][Full Text] [Related]
4. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay.
Sherief MH; Low SH; Miura M; Kudo N; Novick AC; Weimbs T
J Urol; 2003 Apr; 169(4):1530-4. PubMed ID: 12629409
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
Roca F; Mauro LV; Morandi A; Bonadeo F; Vaccaro C; Quintana GO; Specterman S; de Kier Joffé EB; Pallotta MG; Puricelli LI; Lastiri J
J Surg Oncol; 2006 Feb; 93(2):151-60. PubMed ID: 16425303
[TBL] [Abstract][Full Text] [Related]
9. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of basement membrane components in colorectal cancer: prognostic implications.
Lazaris ACh; Tzoumani AN; Thimara I; Theodoropoulos GE; Thomopoulou G; Dicoglou C; Panoussopoulos D; Davaris P
J Exp Clin Cancer Res; 2003 Dec; 22(4):599-606. PubMed ID: 15053302
[TBL] [Abstract][Full Text] [Related]
11. [Distribution and expression of basement membrane proteins in malignant eyelid tumors and its clinical significance].
Lin H; Niu YJ; Zhou ZY; Liu FL; Wang HY
Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):167-71. PubMed ID: 12880575
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients.
Campos RS; Lopes A; Guimarães GC; Carvalho AL; Soares FA
Urology; 2006 Apr; 67(4):797-802. PubMed ID: 16566971
[TBL] [Abstract][Full Text] [Related]
14. Prognostic aspects of the loss of epithelial basement membrane components in preinvasive and invasive laryngeal carcinomas.
Hagedorn HG; Tübel J; Wiest I; Schleicher ED; Nerlich AG
Anticancer Res; 1998; 18(1A):201-7. PubMed ID: 9568078
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
16. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
17. [Role of matrix metalloproteinase-2 and components of the extracellular matrix--collagen type IV and laminin expression in detection of the invasive potential of pancreatic tumors].
Gurevich LE
Arkh Patol; 2003; 65(5):21-5. PubMed ID: 14664143
[TBL] [Abstract][Full Text] [Related]
18. [Study of mechanism on loss of some components from basement membrane in epithelial-interstitial junction in cutaneous pseudoepitheliomatous hyperplasia lesion].
Jiang DY; Fu XB; Sheng ZY; Cheng W; Zhou G; Sun TZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):36-41. PubMed ID: 14706202
[TBL] [Abstract][Full Text] [Related]
19. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
20. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
Claveau I; Mostefaoui Y; Rouabhia M
Matrix Biol; 2004 Nov; 23(7):477-86. PubMed ID: 15579314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
